Kerecis

The new Kerecis Omega3 SurgiBind is an FDA-approved implantable fish-skin graft for use in plastic and reconstructive surgery.

New product and results of clinical study announced at SAWC

Kerecis launches Shield Standard to simplify complex wound treatment.

Kerecis introduces Shield Spiral, a customizable wound care solution.

Bremen Germany — May 5, 2016 — Kerecis, the company using Omega3-rich fish skin to heal human wounds and tissue damage, will present results of human and

Reykjavik / Isafjordur, January 24, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, and the University Hospital of Iceland will

Chronic wounds affect millions of people worldwide: Approximately 6.7 million people in the United States alone suffer from chronic wounds. These wounds are

February 7-13 is National Burn Awareness Week. and the American Burn Association is leading with a 2021 theme of "Electrical Safety from Amps to Zap (A to Z)."

House Appropriations Report Signals Growing Role of Fish‑Skin Regenerative Technologies in Veteran Limb Preservation. Learn more!

Kerecis expands its fish-skin technology to Canada for regenerative wound treatments.

Kerecis presents fish-skin technology at the EWMA DEWU 2026 wound conference.

Kerecis Expands Insurance Coverage for Fish-Skin Grafts – 40 Million Covered Lives Added. Recent policy inclusions across leading U.S. insurers expand access to intact fish‑skin grafts and reinforce their role in treating complex wounds at scale.

Kerecis offers career opportunities for growth.

Meet Daniel Segrefe, a senior account manager based in Cologne, Germany.

Millions more Americans are now eligible for insurance coverage for Kerecis’ medical-fish-skin technology. Many U.S. private insurers recently rated Kerecis

U.S. Reimbursement. Audit-Ready from Kerecis. MariGen is reimbursed by Medicare and has wide coverage through private insurers.

Las Vegas, NV – November 2, 2018 – An economic analysis of a double-blind, prospective, randomized clinical study found that it cost 76 percent more to treat

Kerecis fish-skin grafts recruit more cells than a leading amnion membrane brand.

Aug 20 – 8:00 PM ET – Running a DPM practice in a COVID-19 world is a tricky business. Patients have gained additional complications as they make

Having witnessed the type of damage and human suffering that Kerecis products can help prevent, he has a personal sense of the Kerecis mission.

Kerecis, the fastest growing company in the regenerative-tissue market in the United States, has appointed Mike Cadigan as its chief financial officer (CFO).

Dr. Babich from Texas Foot & Ankle Center will address best practices in patient care in a COVID-19 world.

Kerecis is sustainability. And sustainability is good for both people and business. Kerecis Founder and CEO Fertram Sigurjonsson shared this message in “The

Kerecis offers an educational grant or charitable donation request form for wound and tissue repair.

Ísafjörður, Iceland, is the home of Kerecis, a company with global reach.

Kerecis provides fish-skin substitutes for wound treatment.

Kerecis answers questions about its skin substitute products.

Kerecis uses intact fish skin to treat wounds, burns, and chronic wounds.